{"schemaVersion":"peptidescanner-evidence-bundle/v1","canonicalUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json","manifestUrl":"https://peptidescanner.com/evidence/v1/manifest.json","peptide":{"slug":"etelcalcetide","name":"Etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"},"addressing":"objects is keyed by objectPathId. A URL fragment #<objectPathId> on this file names one evidence object. Every version of a record is placed in the bundle of the record's current first peptide.","objectCount":47,"objects":{"clinicaltrials-gov-nct01134549-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct01134549-etelcalcetide:v1","objectPathId":"clinicaltrials-gov-nct01134549-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01134549-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct01134549-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#clinicaltrials-gov-nct01134549-etelcalcetide-v1"},"story":{"slug":"clinicaltrials-gov-nct01134549-etelcalcetide","version":1,"domain":"Clinical trials","dateInSource":"2017-04-14","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT01134549","sourceIds":["ctg-observation-nct01134549-2017-04-14-e162a3eb799f"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT01134549 at 2026-11-15T22:07:29.454Z. Its registry update date was 2017-04-14, and PeptideScanner's reviewed identity mapping was etelcalcetide.","sourceIds":["ctg-observation-nct01134549-2017-04-14-e162a3eb799f"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT01134549 at 2026-11-15T22:07:29.454Z. Its registry update date was 2017-04-14, and PeptideScanner's reviewed identity mapping was etelcalcetide.","sourceIds":["ctg-observation-nct01134549-2017-04-14-e162a3eb799f"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct01134549-2017-04-14-e162a3eb799f"]}],"sources":[{"id":"ctg-observation-nct01134549-2017-04-14-e162a3eb799f","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT01134549 · retained source version 2017-04-14:e162a3eb799f443f5a0de07c0c5de323fb5ddbb7b7718166e7adcebbad9f76ec","url":"https://clinicaltrials.gov/study/NCT01134549"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"e91154e07a356eae906c47a04c55a352cf9548d4ecb1bf7b614b629efd221839","tierARecordSha256":"6fecbd803ad01f8a6f6466aea498f138637b958dc85b91a24cc865e1e762e666"},"integrity":{"algorithm":"sha256","contentSha256":"9baa489fa485ddb4d06e3f2c2de1cb025ab528c3eaaa2899d60bbb2dbaee96ff"}},"clinicaltrials-gov-nct01134562-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct01134562-etelcalcetide:v1","objectPathId":"clinicaltrials-gov-nct01134562-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01134562-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct01134562-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#clinicaltrials-gov-nct01134562-etelcalcetide-v1"},"story":{"slug":"clinicaltrials-gov-nct01134562-etelcalcetide","version":1,"domain":"Clinical trials","dateInSource":"2018-01-02","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT01134562","sourceIds":["ctg-observation-nct01134562-2018-01-02-94c38b2079c6"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT01134562 at 2026-11-15T22:07:29.454Z. Its registry update date was 2018-01-02, and PeptideScanner's reviewed identity mapping was etelcalcetide.","sourceIds":["ctg-observation-nct01134562-2018-01-02-94c38b2079c6"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT01134562 at 2026-11-15T22:07:29.454Z. Its registry update date was 2018-01-02, and PeptideScanner's reviewed identity mapping was etelcalcetide.","sourceIds":["ctg-observation-nct01134562-2018-01-02-94c38b2079c6"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct01134562-2018-01-02-94c38b2079c6"]}],"sources":[{"id":"ctg-observation-nct01134562-2018-01-02-94c38b2079c6","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT01134562 · retained source version 2018-01-02:94c38b2079c6ac16baef8e464c54252922b7e163b1e93660ad20e3ce36dbc704","url":"https://clinicaltrials.gov/study/NCT01134562"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"76720806d2a9bfff1dd54c074425c1ddf85c3fccb9a064d88a5d93694b117cbe","tierARecordSha256":"0848ad216499f3307564531d3fec79693ea32cd8089f31487fc09b4fc9ef7f24"},"integrity":{"algorithm":"sha256","contentSha256":"315e212fb82e4d86275122785e5a456efa959c8319a0e0acf04b9f2335fa42b5"}},"clinicaltrials-gov-nct01254565-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct01254565-etelcalcetide:v1","objectPathId":"clinicaltrials-gov-nct01254565-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01254565-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct01254565-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#clinicaltrials-gov-nct01254565-etelcalcetide-v1"},"story":{"slug":"clinicaltrials-gov-nct01254565-etelcalcetide","version":1,"domain":"Clinical trials","dateInSource":"2017-04-13","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT01254565","sourceIds":["ctg-observation-nct01254565-2017-04-13-d5af4bd52a16"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT01254565 at 2026-11-15T22:07:29.454Z. Its registry update date was 2017-04-13, and PeptideScanner's reviewed identity mapping was etelcalcetide.","sourceIds":["ctg-observation-nct01254565-2017-04-13-d5af4bd52a16"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT01254565 at 2026-11-15T22:07:29.454Z. Its registry update date was 2017-04-13, and PeptideScanner's reviewed identity mapping was etelcalcetide.","sourceIds":["ctg-observation-nct01254565-2017-04-13-d5af4bd52a16"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct01254565-2017-04-13-d5af4bd52a16"]}],"sources":[{"id":"ctg-observation-nct01254565-2017-04-13-d5af4bd52a16","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT01254565 · retained source version 2017-04-13:d5af4bd52a168b7f4476ccaeec3df9f9759e97b9a12eee7d434cb9bfa9875050","url":"https://clinicaltrials.gov/study/NCT01254565"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"65be6c818aea3b10b696d7bdc9bd340f4147a9f85b97c91628ed09c556edc2f9","tierARecordSha256":"75185af0b69d975059082cdf6b635a622ef034c47b88460fdcfc5e7f83ab359b"},"integrity":{"algorithm":"sha256","contentSha256":"0a393b412e08c1fc20de9b1dc6866acea1735f2ecf418c3d9270a5021a586fb1"}},"clinicaltrials-gov-nct01414114-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct01414114-etelcalcetide:v1","objectPathId":"clinicaltrials-gov-nct01414114-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01414114-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct01414114-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#clinicaltrials-gov-nct01414114-etelcalcetide-v1"},"story":{"slug":"clinicaltrials-gov-nct01414114-etelcalcetide","version":1,"domain":"Clinical trials","dateInSource":"2017-04-11","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT01414114","sourceIds":["ctg-observation-nct01414114-2017-04-11-905af0b0b055"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT01414114 at 2026-11-15T22:07:29.454Z. Its registry update date was 2017-04-11, and PeptideScanner's reviewed identity mapping was etelcalcetide.","sourceIds":["ctg-observation-nct01414114-2017-04-11-905af0b0b055"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT01414114 at 2026-11-15T22:07:29.454Z. Its registry update date was 2017-04-11, and PeptideScanner's reviewed identity mapping was etelcalcetide.","sourceIds":["ctg-observation-nct01414114-2017-04-11-905af0b0b055"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct01414114-2017-04-11-905af0b0b055"]}],"sources":[{"id":"ctg-observation-nct01414114-2017-04-11-905af0b0b055","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT01414114 · retained source version 2017-04-11:905af0b0b055d68ac2166a6f04b0e5e3fffff9585777103f3d8d9dd8d54f3fd9","url":"https://clinicaltrials.gov/study/NCT01414114"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"a656321e3085110a83e02466e3d864770563b047fefe2e9db724a95020e08038","tierARecordSha256":"5f6b3aeca1b1fc0192a52c0a933c46081fb5c7599877d3616c5266094b99d1be"},"integrity":{"algorithm":"sha256","contentSha256":"4eb1c8e9cfbc0bccbe18a02476c52429a876d3bcf04369c18b2fd8157c7c4340"}},"clinicaltrials-gov-nct01785849-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct01785849-etelcalcetide:v1","objectPathId":"clinicaltrials-gov-nct01785849-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01785849-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct01785849-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#clinicaltrials-gov-nct01785849-etelcalcetide-v1"},"story":{"slug":"clinicaltrials-gov-nct01785849-etelcalcetide","version":1,"domain":"Clinical trials","dateInSource":"2019-08-26","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT01785849","sourceIds":["ctg-observation-nct01785849-2019-08-26-e147421c3cb9"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT01785849 at 2026-11-15T22:07:29.454Z. Its registry update date was 2019-08-26, and PeptideScanner's reviewed identity mapping was etelcalcetide.","sourceIds":["ctg-observation-nct01785849-2019-08-26-e147421c3cb9"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT01785849 at 2026-11-15T22:07:29.454Z. Its registry update date was 2019-08-26, and PeptideScanner's reviewed identity mapping was etelcalcetide.","sourceIds":["ctg-observation-nct01785849-2019-08-26-e147421c3cb9"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct01785849-2019-08-26-e147421c3cb9"]}],"sources":[{"id":"ctg-observation-nct01785849-2019-08-26-e147421c3cb9","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT01785849 · retained source version 2019-08-26:e147421c3cb9bfc78e8be2c7d406059fba8cdac33569032d9783804cefd85d61","url":"https://clinicaltrials.gov/study/NCT01785849"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"d2b220e0df76a9e4920d98d7c45d3c8a5903fad735a1567ae771750cdaa9eb78","tierARecordSha256":"24257d81d8c940c342b53ce899608deaa8e220d7609788252d9f43a05af892d8"},"integrity":{"algorithm":"sha256","contentSha256":"21c52cb0c4bb555dd72122961ce8dd243806dc0fd397f5cef93711b6554da498"}},"clinicaltrials-gov-nct01785875-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct01785875-etelcalcetide:v1","objectPathId":"clinicaltrials-gov-nct01785875-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01785875-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct01785875-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#clinicaltrials-gov-nct01785875-etelcalcetide-v1"},"story":{"slug":"clinicaltrials-gov-nct01785875-etelcalcetide","version":1,"domain":"Clinical trials","dateInSource":"2019-04-10","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT01785875","sourceIds":["ctg-observation-nct01785875-2019-04-10-362d2aceb3cf"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT01785875 at 2026-11-15T22:07:29.454Z. Its registry update date was 2019-04-10, and PeptideScanner's reviewed identity mapping was etelcalcetide.","sourceIds":["ctg-observation-nct01785875-2019-04-10-362d2aceb3cf"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT01785875 at 2026-11-15T22:07:29.454Z. Its registry update date was 2019-04-10, and PeptideScanner's reviewed identity mapping was etelcalcetide.","sourceIds":["ctg-observation-nct01785875-2019-04-10-362d2aceb3cf"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct01785875-2019-04-10-362d2aceb3cf"]}],"sources":[{"id":"ctg-observation-nct01785875-2019-04-10-362d2aceb3cf","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT01785875 · retained source version 2019-04-10:362d2aceb3cfdd2babed6a978152434d713b4af85ba0b6e9f0dc393685f60a42","url":"https://clinicaltrials.gov/study/NCT01785875"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"81bbf9afe4e8209129bf438b8f4e667a797518530c76b2a275b3f1b7ab364f81","tierARecordSha256":"6d8c6b079e1fa5c9e4581327d6826bc459e983a2b71d13c030ee1342ec55d849"},"integrity":{"algorithm":"sha256","contentSha256":"b5690976748d541e67c680c42abd0ac204ab6cd8376c8313d076ca5d9b21bef3"}},"clinicaltrials-gov-nct01788046-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct01788046-etelcalcetide:v1","objectPathId":"clinicaltrials-gov-nct01788046-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01788046-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct01788046-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#clinicaltrials-gov-nct01788046-etelcalcetide-v1"},"story":{"slug":"clinicaltrials-gov-nct01788046-etelcalcetide","version":1,"domain":"Clinical trials","dateInSource":"2019-08-20","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT01788046","sourceIds":["ctg-observation-nct01788046-2019-08-20-be650b39b322"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT01788046 at 2026-11-15T22:07:29.454Z. Its registry update date was 2019-08-20, and PeptideScanner's reviewed identity mapping was etelcalcetide.","sourceIds":["ctg-observation-nct01788046-2019-08-20-be650b39b322"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT01788046 at 2026-11-15T22:07:29.454Z. Its registry update date was 2019-08-20, and PeptideScanner's reviewed identity mapping was etelcalcetide.","sourceIds":["ctg-observation-nct01788046-2019-08-20-be650b39b322"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct01788046-2019-08-20-be650b39b322"]}],"sources":[{"id":"ctg-observation-nct01788046-2019-08-20-be650b39b322","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT01788046 · retained source version 2019-08-20:be650b39b322f65fc9ff82bfb418e66ff025a5bbf86cf4424afb89745ad57056","url":"https://clinicaltrials.gov/study/NCT01788046"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"fe5a3a518ed9f156cdb0b2b060d31770ef5ccf9d3efd95c970666efbd6ffa91a","tierARecordSha256":"3b3b5439e002d75f33f68e67924ca4c29501a39e7310c2434bc103e3cc6a4e09"},"integrity":{"algorithm":"sha256","contentSha256":"89fad0488866182726c82509e6a9d6c8a656101443942a38419cb9a02a504e5c"}},"clinicaltrials-gov-nct01896232-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct01896232-etelcalcetide:v1","objectPathId":"clinicaltrials-gov-nct01896232-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01896232-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct01896232-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#clinicaltrials-gov-nct01896232-etelcalcetide-v1"},"story":{"slug":"clinicaltrials-gov-nct01896232-etelcalcetide","version":1,"domain":"Clinical trials","dateInSource":"2019-07-18","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT01896232","sourceIds":["ctg-observation-nct01896232-2019-07-18-eb33ff2ba7a5"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT01896232 at 2026-11-15T22:07:29.454Z. Its registry update date was 2019-07-18, and PeptideScanner's reviewed identity mapping was etelcalcetide.","sourceIds":["ctg-observation-nct01896232-2019-07-18-eb33ff2ba7a5"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT01896232 at 2026-11-15T22:07:29.454Z. Its registry update date was 2019-07-18, and PeptideScanner's reviewed identity mapping was etelcalcetide.","sourceIds":["ctg-observation-nct01896232-2019-07-18-eb33ff2ba7a5"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct01896232-2019-07-18-eb33ff2ba7a5"]}],"sources":[{"id":"ctg-observation-nct01896232-2019-07-18-eb33ff2ba7a5","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT01896232 · retained source version 2019-07-18:eb33ff2ba7a5b8f304a37fdb41da209531183ecb280a8174ce184793fb6ef13c","url":"https://clinicaltrials.gov/study/NCT01896232"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"1abd1e333ed1bfa04ce94f0ece0c9996d6e33a7aa00df3c5d595a4e8e5b72258","tierARecordSha256":"b7de15e4fb2edc4a900d0e01b11707c2927ad954c154699b2f3882bb1437172f"},"integrity":{"algorithm":"sha256","contentSha256":"7e721c5f5c103029214a62b90e610c3070927a44658a996ab92892b5eb413651"}},"clinicaltrials-gov-nct01932970-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct01932970-etelcalcetide:v1","objectPathId":"clinicaltrials-gov-nct01932970-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01932970-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct01932970-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#clinicaltrials-gov-nct01932970-etelcalcetide-v1"},"story":{"slug":"clinicaltrials-gov-nct01932970-etelcalcetide","version":1,"domain":"Clinical trials","dateInSource":"2018-10-17","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT01932970","sourceIds":["ctg-observation-nct01932970-2018-10-17-85d8837c2345"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT01932970 at 2026-11-15T22:07:29.454Z. Its registry update date was 2018-10-17, and PeptideScanner's reviewed identity mapping was etelcalcetide.","sourceIds":["ctg-observation-nct01932970-2018-10-17-85d8837c2345"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT01932970 at 2026-11-15T22:07:29.454Z. Its registry update date was 2018-10-17, and PeptideScanner's reviewed identity mapping was etelcalcetide.","sourceIds":["ctg-observation-nct01932970-2018-10-17-85d8837c2345"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct01932970-2018-10-17-85d8837c2345"]}],"sources":[{"id":"ctg-observation-nct01932970-2018-10-17-85d8837c2345","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT01932970 · retained source version 2018-10-17:85d8837c2345fddcf04742f37967eae81cf24b9429644f7c4f2191425cedea8c","url":"https://clinicaltrials.gov/study/NCT01932970"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"a85df03f67c425609534b6a17de16de6b4ae12c2140aaf1d2476249ef8d2678a","tierARecordSha256":"1c4ab3d010f50601d1076755ec47f18df4c4eabb132bab5446cc2656433d7978"},"integrity":{"algorithm":"sha256","contentSha256":"04e10df796516ad9060fff4563cd8eadf255218746d1758b1fa59e201b54e0d4"}},"clinicaltrials-gov-nct02102204-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct02102204-etelcalcetide:v1","objectPathId":"clinicaltrials-gov-nct02102204-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02102204-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct02102204-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#clinicaltrials-gov-nct02102204-etelcalcetide-v1"},"story":{"slug":"clinicaltrials-gov-nct02102204-etelcalcetide","version":1,"domain":"Clinical trials","dateInSource":"2017-11-17","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT02102204","sourceIds":["ctg-observation-nct02102204-2017-11-17-85bee952a46d"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT02102204 at 2026-11-15T22:07:29.454Z. Its registry update date was 2017-11-17, and PeptideScanner's reviewed identity mapping was etelcalcetide.","sourceIds":["ctg-observation-nct02102204-2017-11-17-85bee952a46d"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT02102204 at 2026-11-15T22:07:29.454Z. Its registry update date was 2017-11-17, and PeptideScanner's reviewed identity mapping was etelcalcetide.","sourceIds":["ctg-observation-nct02102204-2017-11-17-85bee952a46d"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct02102204-2017-11-17-85bee952a46d"]}],"sources":[{"id":"ctg-observation-nct02102204-2017-11-17-85bee952a46d","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT02102204 · retained source version 2017-11-17:85bee952a46d8998ba3cc8fa8a72507e953d63ff8d2a6425006c55b654e3de50","url":"https://clinicaltrials.gov/study/NCT02102204"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"a15dc3a0969297de59afe013a9afcba7b963dad2da6a096cb9dca2bc8d6d40b8","tierARecordSha256":"6f6f52b530ce8dfdfe673b8876c1aafe376ef7bb938ad809bb10090a814e223c"},"integrity":{"algorithm":"sha256","contentSha256":"04983c77988bc4ae039a353cab1d98399d320745a3318e171cc97de79fe3208f"}},"clinicaltrials-gov-nct02833857-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct02833857-etelcalcetide:v1","objectPathId":"clinicaltrials-gov-nct02833857-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02833857-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct02833857-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#clinicaltrials-gov-nct02833857-etelcalcetide-v1"},"story":{"slug":"clinicaltrials-gov-nct02833857-etelcalcetide","version":1,"domain":"Clinical trials","dateInSource":"2019-07-10","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT02833857","sourceIds":["ctg-observation-nct02833857-2019-07-10-594d0112c2cf"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT02833857 at 2026-11-15T22:07:29.454Z. Its registry update date was 2019-07-10, and PeptideScanner's reviewed identity mapping was etelcalcetide.","sourceIds":["ctg-observation-nct02833857-2019-07-10-594d0112c2cf"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT02833857 at 2026-11-15T22:07:29.454Z. Its registry update date was 2019-07-10, and PeptideScanner's reviewed identity mapping was etelcalcetide.","sourceIds":["ctg-observation-nct02833857-2019-07-10-594d0112c2cf"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct02833857-2019-07-10-594d0112c2cf"]}],"sources":[{"id":"ctg-observation-nct02833857-2019-07-10-594d0112c2cf","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT02833857 · retained source version 2019-07-10:594d0112c2cfa1cbfd2b0ddb1a46b15f1ddcd0376d12023a881a7cbfae51e036","url":"https://clinicaltrials.gov/study/NCT02833857"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"5005347fa04b4a7adf1308c6b681ffe9d17c83e00ff267bff3e93eded9de2887","tierARecordSha256":"0fff82811bcbbe40163a38690ca069903671a820597cacdb90e8b540c51d72a9"},"integrity":{"algorithm":"sha256","contentSha256":"c06d6f6aa6948f677f1245db313c8d47ecb786b3f5d5c71e0bb42301690c6627"}},"clinicaltrials-gov-nct03283098-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct03283098-etelcalcetide:v1","objectPathId":"clinicaltrials-gov-nct03283098-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03283098-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct03283098-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#clinicaltrials-gov-nct03283098-etelcalcetide-v1"},"story":{"slug":"clinicaltrials-gov-nct03283098-etelcalcetide","version":1,"domain":"Clinical trials","dateInSource":"2020-02-10","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT03283098","sourceIds":["ctg-observation-nct03283098-2020-02-10-f87a14e29762"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT03283098 at 2026-11-15T22:07:29.454Z. Its registry update date was 2020-02-10, and PeptideScanner's reviewed identity mapping was etelcalcetide.","sourceIds":["ctg-observation-nct03283098-2020-02-10-f87a14e29762"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT03283098 at 2026-11-15T22:07:29.454Z. Its registry update date was 2020-02-10, and PeptideScanner's reviewed identity mapping was etelcalcetide.","sourceIds":["ctg-observation-nct03283098-2020-02-10-f87a14e29762"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct03283098-2020-02-10-f87a14e29762"]}],"sources":[{"id":"ctg-observation-nct03283098-2020-02-10-f87a14e29762","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT03283098 · retained source version 2020-02-10:f87a14e29762d147c51bccdd3ea03ee4055ebd015c7a68236d7b1e7e355f02eb","url":"https://clinicaltrials.gov/study/NCT03283098"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"148991a6815d9ed939b379040079296750a7ebbbc4a2ee9ed7f4c2e52477d6f8","tierARecordSha256":"89ee41cf77a55e6c02a64b15c3fb0c5973d1813114d6005303a0a38ecbdb964d"},"integrity":{"algorithm":"sha256","contentSha256":"56b835f78bc82fb7b1a27944905596f3ee392d80103718b46faa72d6c45677d4"}},"clinicaltrials-gov-nct03299244-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct03299244-etelcalcetide:v1","objectPathId":"clinicaltrials-gov-nct03299244-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03299244-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct03299244-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#clinicaltrials-gov-nct03299244-etelcalcetide-v1"},"story":{"slug":"clinicaltrials-gov-nct03299244-etelcalcetide","version":1,"domain":"Clinical trials","dateInSource":"2021-04-30","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT03299244","sourceIds":["ctg-observation-nct03299244-2021-04-30-cca0785f47ad"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT03299244 at 2026-11-15T22:07:29.454Z. Its registry update date was 2021-04-30, and PeptideScanner's reviewed identity mapping was etelcalcetide.","sourceIds":["ctg-observation-nct03299244-2021-04-30-cca0785f47ad"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT03299244 at 2026-11-15T22:07:29.454Z. Its registry update date was 2021-04-30, and PeptideScanner's reviewed identity mapping was etelcalcetide.","sourceIds":["ctg-observation-nct03299244-2021-04-30-cca0785f47ad"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct03299244-2021-04-30-cca0785f47ad"]}],"sources":[{"id":"ctg-observation-nct03299244-2021-04-30-cca0785f47ad","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT03299244 · retained source version 2021-04-30:cca0785f47adb3960d566ea9e16205f944438ab809ed10c00de82d5161cf5d68","url":"https://clinicaltrials.gov/study/NCT03299244"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"b813800ae853111d95108d8a90d905dd3a40ef72006ef77872315ef59aa4a328","tierARecordSha256":"7f0a218ebb56261d6dc17b730828521ad41068d460567169132205024b2f35e0"},"integrity":{"algorithm":"sha256","contentSha256":"81c3bc8af3f42e8eaf6aaa8cc241b0e689ebf906f1bea3cbdd53bab5ca2265b5"}},"clinicaltrials-gov-nct03633708-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct03633708-etelcalcetide:v1","objectPathId":"clinicaltrials-gov-nct03633708-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03633708-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct03633708-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#clinicaltrials-gov-nct03633708-etelcalcetide-v1"},"story":{"slug":"clinicaltrials-gov-nct03633708-etelcalcetide","version":1,"domain":"Clinical trials","dateInSource":"2026-02-27","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT03633708","sourceIds":["ctg-observation-nct03633708-2026-02-27-38bd6b4ba7d6"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT03633708 at 2026-11-15T22:07:29.454Z. Its registry update date was 2026-02-27, and PeptideScanner's reviewed identity mapping was etelcalcetide.","sourceIds":["ctg-observation-nct03633708-2026-02-27-38bd6b4ba7d6"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT03633708 at 2026-11-15T22:07:29.454Z. Its registry update date was 2026-02-27, and PeptideScanner's reviewed identity mapping was etelcalcetide.","sourceIds":["ctg-observation-nct03633708-2026-02-27-38bd6b4ba7d6"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct03633708-2026-02-27-38bd6b4ba7d6"]}],"sources":[{"id":"ctg-observation-nct03633708-2026-02-27-38bd6b4ba7d6","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT03633708 · retained source version 2026-02-27:38bd6b4ba7d6ef76f95277bedfbe8d94c999deec36829fb9e54a557f6ffa215e","url":"https://clinicaltrials.gov/study/NCT03633708"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"63f58087a7c1c80a36eafc7d7c0343ad2fc41863a71b01729219556e0507e182","tierARecordSha256":"323623d696c6e6ca1b2d5d3e6c19626563f3e5c063669d2191ff1b9c06b78731"},"integrity":{"algorithm":"sha256","contentSha256":"0ce8983a52e04004247ec54e7e1f994a8ef40f77051a5ef50a2c23a15673ac6f"}},"clinicaltrials-gov-nct03795558-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct03795558-etelcalcetide:v1","objectPathId":"clinicaltrials-gov-nct03795558-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03795558-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct03795558-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#clinicaltrials-gov-nct03795558-etelcalcetide-v1"},"story":{"slug":"clinicaltrials-gov-nct03795558-etelcalcetide","version":1,"domain":"Clinical trials","dateInSource":"2022-03-23","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT03795558","sourceIds":["ctg-observation-nct03795558-2022-03-23-714d9fec5ddb"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT03795558 at 2026-11-15T22:07:29.454Z. Its registry update date was 2022-03-23, and PeptideScanner's reviewed identity mapping was etelcalcetide.","sourceIds":["ctg-observation-nct03795558-2022-03-23-714d9fec5ddb"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT03795558 at 2026-11-15T22:07:29.454Z. Its registry update date was 2022-03-23, and PeptideScanner's reviewed identity mapping was etelcalcetide.","sourceIds":["ctg-observation-nct03795558-2022-03-23-714d9fec5ddb"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct03795558-2022-03-23-714d9fec5ddb"]}],"sources":[{"id":"ctg-observation-nct03795558-2022-03-23-714d9fec5ddb","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT03795558 · retained source version 2022-03-23:714d9fec5ddb03844477ba707fb019dad9016f9d6197901bfddde9856d67f2bb","url":"https://clinicaltrials.gov/study/NCT03795558"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"13dbab40d3c599792550e3b217ce44f1deab83a050855f45abba131159aeb916","tierARecordSha256":"9d06c9bfff4908b9df9dbee3e13aab87d40e3134feb9f9cbbfa7221e4d50d957"},"integrity":{"algorithm":"sha256","contentSha256":"c8ae750aec358efa6fa0d1a1df3e391db87bc152ba732f7dfb7b65a8eb9d6fc7"}},"clinicaltrials-gov-nct03960437-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct03960437-etelcalcetide:v1","objectPathId":"clinicaltrials-gov-nct03960437-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03960437-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct03960437-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#clinicaltrials-gov-nct03960437-etelcalcetide-v1"},"story":{"slug":"clinicaltrials-gov-nct03960437-etelcalcetide","version":1,"domain":"Clinical trials","dateInSource":"2023-09-21","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT03960437","sourceIds":["ctg-observation-nct03960437-2023-09-21-a95ebb1e5298"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT03960437 at 2026-11-15T22:07:29.454Z. Its registry update date was 2023-09-21, and PeptideScanner's reviewed identity mapping was etelcalcetide.","sourceIds":["ctg-observation-nct03960437-2023-09-21-a95ebb1e5298"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT03960437 at 2026-11-15T22:07:29.454Z. Its registry update date was 2023-09-21, and PeptideScanner's reviewed identity mapping was etelcalcetide.","sourceIds":["ctg-observation-nct03960437-2023-09-21-a95ebb1e5298"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct03960437-2023-09-21-a95ebb1e5298"]}],"sources":[{"id":"ctg-observation-nct03960437-2023-09-21-a95ebb1e5298","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT03960437 · retained source version 2023-09-21:a95ebb1e52985d05aa4b30be9354456e5b01f8726a9c1c50b104f65fdcf68068","url":"https://clinicaltrials.gov/study/NCT03960437"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"c1e214a1f0daafa84eb87d9dc683b9d6e3c26dfbe623bf075f28b782d6e3d1f0","tierARecordSha256":"6ec4dd4b6ad8c5bf49c980de90f79b1d7229c7fcc272c97ed0dd09e932ab6e10"},"integrity":{"algorithm":"sha256","contentSha256":"bb80f1d628dbed1960599e2aa8f8cb9b6fc044f628d2959760830da9fa45eb29"}},"clinicaltrials-gov-nct03969329-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct03969329-etelcalcetide:v1","objectPathId":"clinicaltrials-gov-nct03969329-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03969329-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct03969329-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#clinicaltrials-gov-nct03969329-etelcalcetide-v1"},"story":{"slug":"clinicaltrials-gov-nct03969329-etelcalcetide","version":1,"domain":"Clinical trials","dateInSource":"2026-08-21","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT03969329","sourceIds":["ctg-observation-nct03969329-2026-08-21-b697ecb9dcc1"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT03969329 at 2026-11-15T22:07:29.454Z. Its registry update date was 2026-08-21, and PeptideScanner's reviewed identity mapping was etelcalcetide.","sourceIds":["ctg-observation-nct03969329-2026-08-21-b697ecb9dcc1"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT03969329 at 2026-11-15T22:07:29.454Z. Its registry update date was 2026-08-21, and PeptideScanner's reviewed identity mapping was etelcalcetide.","sourceIds":["ctg-observation-nct03969329-2026-08-21-b697ecb9dcc1"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct03969329-2026-08-21-b697ecb9dcc1"]}],"sources":[{"id":"ctg-observation-nct03969329-2026-08-21-b697ecb9dcc1","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT03969329 · retained source version 2026-08-21:b697ecb9dcc1da80bf6d315fc61b3903302180345469329ae5a25b55c7bc5c10","url":"https://clinicaltrials.gov/study/NCT03969329"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"61181ed45ee17e7a907f2b45f72d4f9f898bf188c3b11ba3b11d275cda71e7dc","tierARecordSha256":"9d8908b741d0efdc876f26c64db2dab73185402388f555d9263db647047f7d0e"},"integrity":{"algorithm":"sha256","contentSha256":"a6594d8f3d4a1178728af858cc981dc1f4c0eeeb19904643c5b2309e73fc1974"}},"fda-drugs-nda208325-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:fda-drugs-nda208325:v1","objectPathId":"fda-drugs-nda208325-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/fda-drugs-nda208325/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#fda-drugs-nda208325-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#fda-drugs-nda208325-v1"},"story":{"slug":"fda-drugs-nda208325","version":1,"domain":"Regulatory","dateInSource":"2017-02-07","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"Drugs@FDA application NDA208325","sourceIds":["fda-drugs-nda208325-2017-02-07-023620f05ec6"]},{"id":"summary","text":"The official Drugs@FDA dataset lists original submission 1 for NDA 208325 with status AP dated 2017-02-07, and names etelcalcetide among the application record's active ingredients.","sourceIds":["fda-drugs-nda208325-2017-02-07-023620f05ec6"]},{"id":"paragraph-1","text":"The official Drugs@FDA dataset lists original submission 1 for NDA 208325 with status AP dated 2017-02-07, and names etelcalcetide among the application record's active ingredients.","sourceIds":["fda-drugs-nda208325-2017-02-07-023620f05ec6"]},{"id":"paragraph-2","text":"This page reports bounded application metadata attributed to Drugs@FDA. It does not reproduce labeling, describe an indication, compare products, or provide medical guidance.","sourceIds":["fda-drugs-nda208325-2017-02-07-023620f05ec6"]}],"sources":[{"id":"fda-drugs-nda208325-2017-02-07-023620f05ec6","name":"Drugs@FDA via openFDA","sourceClass":"A","title":"Drugs@FDA application NDA208325 · original submission status AP · 2017-02-07 · dataset 2026-11-13","url":"https://api.fda.gov/drug/drugsfda.json?search=application_number%3A%22NDA208325%22&limit=1"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"ededa5aef44fb5ad045f94414d5c41b57beea7a49fb895dd78c2c03abe7615b2","tierARecordSha256":"023620f05ec63652c4a05c2edd7cff3c43a8275a7e3550f8e5c4e3f56515d27a"},"integrity":{"algorithm":"sha256","contentSha256":"3e975597818d1cda2fdddcfa6762d3e39c2e782724bc7859485c3ae2f97f107c"}},"federal-register-2018-28221-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:federal-register-2018-28221:v1","objectPathId":"federal-register-2018-28221-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/federal-register-2018-28221/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#federal-register-2018-28221-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#federal-register-2018-28221-v1"},"story":{"slug":"federal-register-2018-28221","version":1,"domain":"Regulatory","dateInSource":"2018-12-28","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"Federal Register notice 2018-28221","sourceIds":["federal-register-2018-28221-e300dd1839c7"]},{"id":"summary","text":"The Federal Register published notice 2018-28221, attributed to FDA and its parent HHS department, on 2018-12-28. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; PARSABIV,” and PeptideScanner's exact reviewed identity mapping connects the document to Etelcalcetide.","sourceIds":["federal-register-2018-28221-e300dd1839c7"]},{"id":"paragraph-1","text":"The Federal Register published notice 2018-28221, attributed to FDA and its parent HHS department, on 2018-12-28. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; PARSABIV,” and PeptideScanner's exact reviewed identity mapping connects the document to Etelcalcetide.","sourceIds":["federal-register-2018-28221-e300dd1839c7"]},{"id":"paragraph-2","text":"This page reports bounded metadata from a Federal Register document attributed to FDA and its parent HHS department, and links to the official GovInfo PDF. It does not interpret legal effect, approval, safety, effectiveness, compounding status, or medical use.","sourceIds":["federal-register-2018-28221-e300dd1839c7"]}],"sources":[{"id":"federal-register-2018-28221-e300dd1839c7","name":"Federal Register via GovInfo","sourceClass":"A","title":"Federal Register notice 2018-28221 · published 2018-12-28 · Determination of Regulatory Review Period for Purposes of Patent Extension; PARSABIV","url":"https://www.govinfo.gov/content/pkg/FR-2018-12-28/pdf/2018-28221.pdf"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"6e6c50b95dfc8f97ff8dc0a330b837bc1eccdc8a9b8b3c70f41d0f77a52a5f3f","tierARecordSha256":"e300dd1839c73898768aea10d096dc8bef87954510fe6f23468718893842b182"},"integrity":{"algorithm":"sha256","contentSha256":"10265bbdbb0c3e0e5d25593152dd3e1a81291772b4280abc4dfc84b553eacb23"}},"pubmed-pmid-27639083-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-27639083-etelcalcetide:v1","objectPathId":"pubmed-pmid-27639083-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-27639083-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-27639083-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-27639083-etelcalcetide-v1"},"story":{"slug":"pubmed-pmid-27639083-etelcalcetide","version":1,"domain":"Literature metadata","dateInSource":"2019-12-10","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"Population Pharmacokinetics and Pharmacodynamics of the Calcimimetic Etelcalcetide in Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Hemodialysis.","sourceIds":["pubmed-observation-pmid-27639083-2019-12-10-68bd2ce3fe0c"]},{"id":"summary","text":"PubMed lists PMID 27639083 in CPT: pharmacometrics & systems pharmacology as Journal Article, with publication-date metadata of 2016-09-17 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-27639083-2019-12-10-68bd2ce3fe0c"]},{"id":"paragraph-1","text":"PubMed lists PMID 27639083 in CPT: pharmacometrics & systems pharmacology as Journal Article, with publication-date metadata of 2016-09-17 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-27639083-2019-12-10-68bd2ce3fe0c"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-27639083-2019-12-10-68bd2ce3fe0c"]}],"sources":[{"id":"pubmed-observation-pmid-27639083-2019-12-10-68bd2ce3fe0c","name":"PubMed","sourceClass":"A","title":"Population Pharmacokinetics and Pharmacodynamics of the Calcimimetic Etelcalcetide in Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Hemodialysis. · retained source version 1:2019-12-10:current:68bd2ce3fe0c1d044d44bba4ac22a9ed8e6c0c0c0da10999ae9c4ae52c0f9e64","url":"https://pubmed.ncbi.nlm.nih.gov/27639083/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"3365c7197b3b206a0c3b0e168a7faac4eb87b888da8132c191c4cea32e24b6f3","tierARecordSha256":"08d7954caa9cbb116fa60d809a11c2d19414d3c3e756798b5ee16fa51ab58896"},"integrity":{"algorithm":"sha256","contentSha256":"9d6da84f6280f053ae1d8d866f6e15c32d25aacb1c8df5fe43b617fb3bd68c5a"}},"pubmed-pmid-28063122-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-28063122-etelcalcetide:v1","objectPathId":"pubmed-pmid-28063122-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-28063122-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-28063122-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-28063122-etelcalcetide-v1"},"story":{"slug":"pubmed-pmid-28063122-etelcalcetide","version":1,"domain":"Literature metadata","dateInSource":"2026-10-11","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"Drug disposition model of radiolabeled etelcalcetide in patients with chronic kidney disease and secondary hyperparathyroidism on hemodialysis.","sourceIds":["pubmed-observation-pmid-28063122-2026-10-11-6468e78b57c0"]},{"id":"summary","text":"PubMed lists PMID 28063122 in Journal of pharmacokinetics and pharmacodynamics as Journal Article, with publication-date metadata of 2017-01-06 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-28063122-2026-10-11-6468e78b57c0"]},{"id":"paragraph-1","text":"PubMed lists PMID 28063122 in Journal of pharmacokinetics and pharmacodynamics as Journal Article, with publication-date metadata of 2017-01-06 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-28063122-2026-10-11-6468e78b57c0"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-28063122-2026-10-11-6468e78b57c0"]}],"sources":[{"id":"pubmed-observation-pmid-28063122-2026-10-11-6468e78b57c0","name":"PubMed","sourceClass":"A","title":"Drug disposition model of radiolabeled etelcalcetide in patients with chronic kidney disease and secondary hyperparathyroidism on hemodialysis. · retained source version 1:2026-10-11:current:6468e78b57c004bcf950b332f5cc738720e6b42b14d379d01da825a46dba9250","url":"https://pubmed.ncbi.nlm.nih.gov/28063122/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"e781862745a41dc4d5d8cb2396367b6eef27b2c8ce6b3293c24329054acebdc3","tierARecordSha256":"00a565708525fb9fbb685c6134c6265114c3de59d0b717abab094a3f78b9e46d"},"integrity":{"algorithm":"sha256","contentSha256":"277dd4469064d0b3db69cf6f56d71be921d5a923a7a2edfb5e4c8bec734e7867"}},"pubmed-pmid-28277829-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-28277829-etelcalcetide:v1","objectPathId":"pubmed-pmid-28277829-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-28277829-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-28277829-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-28277829-etelcalcetide-v1"},"story":{"slug":"pubmed-pmid-28277829-etelcalcetide","version":1,"domain":"Literature metadata","dateInSource":"2019-12-10","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"Etelcalcetide for the treatment of secondary hyperparathyroidism.","sourceIds":["pubmed-observation-pmid-28277829-2019-12-10-5c6e83aa1d93"]},{"id":"summary","text":"PubMed lists PMID 28277829 in Expert opinion on pharmacotherapy as Comparative Study, Journal Article, Review, with publication-date metadata of 2017-03-15 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-28277829-2019-12-10-5c6e83aa1d93"]},{"id":"paragraph-1","text":"PubMed lists PMID 28277829 in Expert opinion on pharmacotherapy as Comparative Study, Journal Article, Review, with publication-date metadata of 2017-03-15 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-28277829-2019-12-10-5c6e83aa1d93"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-28277829-2019-12-10-5c6e83aa1d93"]}],"sources":[{"id":"pubmed-observation-pmid-28277829-2019-12-10-5c6e83aa1d93","name":"PubMed","sourceClass":"A","title":"Etelcalcetide for the treatment of secondary hyperparathyroidism. · retained source version 1:2019-12-10:current:5c6e83aa1d93c34a9a820fe8905a227702325cb60d999b410b45a8e081327aa1","url":"https://pubmed.ncbi.nlm.nih.gov/28277829/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"c099bd8c3c53e12cc99348e3d3cfef3e5c0c9ca9cff4d3eb6a9b0a2c29bdb805","tierARecordSha256":"5e76ce11b532756b30adce3614ff4b9e4bfcd89e937a7feb9ca7d2ee1e8a76c5"},"integrity":{"algorithm":"sha256","contentSha256":"6f0fae6242c40f7024585b0c157aa4afef2c74b4fbc7767d4bf6f9bd5165500c"}},"pubmed-pmid-28508378-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-28508378-etelcalcetide:v1","objectPathId":"pubmed-pmid-28508378-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-28508378-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-28508378-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-28508378-etelcalcetide-v1"},"story":{"slug":"pubmed-pmid-28508378-etelcalcetide","version":1,"domain":"Literature metadata","dateInSource":"2019-12-10","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"Population Pharmacokinetic and Pharmacodynamic Modeling of Etelcalcetide in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Hemodialysis.","sourceIds":["pubmed-observation-pmid-28508378-2019-12-10-ba605561a097"]},{"id":"summary","text":"PubMed lists PMID 28508378 in Clinical pharmacokinetics as Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, with publication-date metadata of 2018-01 (month precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-28508378-2019-12-10-ba605561a097"]},{"id":"paragraph-1","text":"PubMed lists PMID 28508378 in Clinical pharmacokinetics as Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, with publication-date metadata of 2018-01 (month precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-28508378-2019-12-10-ba605561a097"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-28508378-2019-12-10-ba605561a097"]}],"sources":[{"id":"pubmed-observation-pmid-28508378-2019-12-10-ba605561a097","name":"PubMed","sourceClass":"A","title":"Population Pharmacokinetic and Pharmacodynamic Modeling of Etelcalcetide in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Hemodialysis. · retained source version 1:2019-12-10:current:ba605561a0978eaa8959d5c02b776b217c53b9b170b554ee429b22d8178da4d5","url":"https://pubmed.ncbi.nlm.nih.gov/28508378/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"abe11f2ca611fd0e006d114d3f0eac9917d0c8d3a61f7b02bb8aeb48aaa72f0a","tierARecordSha256":"df46fd1ab26c4ce633848060d387aeea82c6e26cb7495915189502426a4aa386"},"integrity":{"algorithm":"sha256","contentSha256":"8a897acb6977c867da954f7ef6798ff99f6c4b90f62ca81ae8f7fef8b1093e91"}},"pubmed-pmid-28615947-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-28615947-etelcalcetide:v1","objectPathId":"pubmed-pmid-28615947-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-28615947-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-28615947-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-28615947-etelcalcetide-v1"},"story":{"slug":"pubmed-pmid-28615947-etelcalcetide","version":1,"domain":"Literature metadata","dateInSource":"2024-03-26","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide.","sourceIds":["pubmed-observation-pmid-28615947-2024-03-26-bd82592c1ecf"]},{"id":"summary","text":"PubMed lists PMID 28615947 in Therapeutics and clinical risk management as Journal Article, Review, with publication-date metadata of 2017-06-01 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-28615947-2024-03-26-bd82592c1ecf"]},{"id":"paragraph-1","text":"PubMed lists PMID 28615947 in Therapeutics and clinical risk management as Journal Article, Review, with publication-date metadata of 2017-06-01 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-28615947-2024-03-26-bd82592c1ecf"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-28615947-2024-03-26-bd82592c1ecf"]}],"sources":[{"id":"pubmed-observation-pmid-28615947-2024-03-26-bd82592c1ecf","name":"PubMed","sourceClass":"A","title":"Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide. · retained source version 1:2024-03-26:current:bd82592c1ecff67f001e44658e7d0feb512158e583a104ebd5100b5e60998dcd","url":"https://pubmed.ncbi.nlm.nih.gov/28615947/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"bae799c27acb57a2389089519c3750f3f1c3989bf031b4faa7626a82c56212b7","tierARecordSha256":"020682444a63fb6864d6273b9af8a25d4f275afd43852c1662737a47bb28c09e"},"integrity":{"algorithm":"sha256","contentSha256":"a0ee2f6abc7fd820260030fa83d7cf47c9658ccdd7beac4f77ba6602648aee98"}},"pubmed-pmid-28661841-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-28661841-etelcalcetide:v1","objectPathId":"pubmed-pmid-28661841-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-28661841-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-28661841-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-28661841-etelcalcetide-v1"},"story":{"slug":"pubmed-pmid-28661841-etelcalcetide","version":1,"domain":"Literature metadata","dateInSource":"2019-05-23","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"Parsabiv Could Be Pricey Addition In Care for CKD, ESRD Patients.","sourceIds":["pubmed-observation-pmid-28661841-2019-05-23-6392fb4e3acc"]},{"id":"summary","text":"PubMed lists PMID 28661841 in Managed care (Langhorne, Pa.) as Journal Article, with publication-date metadata of 2017-06 (month precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-28661841-2019-05-23-6392fb4e3acc"]},{"id":"paragraph-1","text":"PubMed lists PMID 28661841 in Managed care (Langhorne, Pa.) as Journal Article, with publication-date metadata of 2017-06 (month precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-28661841-2019-05-23-6392fb4e3acc"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-28661841-2019-05-23-6392fb4e3acc"]}],"sources":[{"id":"pubmed-observation-pmid-28661841-2019-05-23-6392fb4e3acc","name":"PubMed","sourceClass":"A","title":"Parsabiv Could Be Pricey Addition In Care for CKD, ESRD Patients. · retained source version 1:2019-05-23:current:6392fb4e3accd98a658594da6601a962c7a44febafcb77d8dd6535fa1f0f49e2","url":"https://pubmed.ncbi.nlm.nih.gov/28661841/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"641b075bc6fe50e5cb1287eeae1a55bc93a4a1da9f1babe12a5b8a32f7510a94","tierARecordSha256":"e7cae7e3606ead006b50a524329410ee1cd68140587605b346713c92e24c48a7"},"integrity":{"algorithm":"sha256","contentSha256":"e9ddf090149d2617c753669a3b4531e2c410228ae7200555addfca919c328ff3"}},"pubmed-pmid-28867373-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-28867373-etelcalcetide:v1","objectPathId":"pubmed-pmid-28867373-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-28867373-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-28867373-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-28867373-etelcalcetide-v1"},"story":{"slug":"pubmed-pmid-28867373-etelcalcetide","version":1,"domain":"Literature metadata","dateInSource":"2021-12-04","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"Etelcalcetide (AMG 416), a peptide agonist of the calcium-sensing receptor, preserved cortical bone structure and bone strength in subtotal nephrectomized rats with established secondary hyperparathy…","sourceIds":["pubmed-observation-pmid-28867373-2021-12-04-e3d7795bc8d4"]},{"id":"summary","text":"PubMed lists PMID 28867373 in Bone as Journal Article, with publication-date metadata of 2017-09-01 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-28867373-2021-12-04-e3d7795bc8d4"]},{"id":"paragraph-1","text":"PubMed lists PMID 28867373 in Bone as Journal Article, with publication-date metadata of 2017-09-01 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-28867373-2021-12-04-e3d7795bc8d4"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-28867373-2021-12-04-e3d7795bc8d4"]}],"sources":[{"id":"pubmed-observation-pmid-28867373-2021-12-04-e3d7795bc8d4","name":"PubMed","sourceClass":"A","title":"Etelcalcetide (AMG 416), a peptide agonist of the calcium-sensing receptor, preserved cortical bone structure and bone strength in subtotal nephrectomized rats with established secondary hyperparathyroidism. · retained source version 1:2021-12-04:current:e3d7795bc8d4ec29296b8207454996bf01626e567a364ff25b7bf392b2fe82a8","url":"https://pubmed.ncbi.nlm.nih.gov/28867373/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"79a2d6a6d469a4684f01e2a1c09b357a41d4e1c579510a6f99dd371cd4df6c94","tierARecordSha256":"147feee8021124626d40b6a2763672c4872355b4d9461bba4f403dd05501b9ba"},"integrity":{"algorithm":"sha256","contentSha256":"b23384b9cd286b029a48fb4cb6feb83ef6997ba4b64eb465cb6356c34645210d"}},"pubmed-pmid-29276237-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-29276237-etelcalcetide:v1","objectPathId":"pubmed-pmid-29276237-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-29276237-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-29276237-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-29276237-etelcalcetide-v1"},"story":{"slug":"pubmed-pmid-29276237-etelcalcetide","version":1,"domain":"Literature metadata","dateInSource":"2019-11-20","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"Formulary Drug Review: Etelcalcetide.","sourceIds":["pubmed-observation-pmid-29276237-2019-11-20-007471494e9f"]},{"id":"summary","text":"PubMed lists PMID 29276237 in Hospital pharmacy as Journal Article, Review, with publication-date metadata of 2017-09-25 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-29276237-2019-11-20-007471494e9f"]},{"id":"paragraph-1","text":"PubMed lists PMID 29276237 in Hospital pharmacy as Journal Article, Review, with publication-date metadata of 2017-09-25 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-29276237-2019-11-20-007471494e9f"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-29276237-2019-11-20-007471494e9f"]}],"sources":[{"id":"pubmed-observation-pmid-29276237-2019-11-20-007471494e9f","name":"PubMed","sourceClass":"A","title":"Formulary Drug Review: Etelcalcetide. · retained source version 1:2019-11-20:current:007471494e9fc5360ea70f0b481bb68335e37dc70168a36bd3189685e095f867","url":"https://pubmed.ncbi.nlm.nih.gov/29276237/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"203867fd90d92157248f51b0e4cd6c23be4033cbfdf51148c0ee4b3785122da8","tierARecordSha256":"f15b7524ae86c71ad6b3b33b9003fadb798de0eea5c0c728a40b93ccf5bc0104"},"integrity":{"algorithm":"sha256","contentSha256":"2e280f3ed70aa93ee9e5d5bc4694f5133fc3bab8539fcb43c514f692272efc42"}},"pubmed-pmid-29440923-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-29440923-etelcalcetide:v1","objectPathId":"pubmed-pmid-29440923-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-29440923-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-29440923-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-29440923-etelcalcetide-v1"},"story":{"slug":"pubmed-pmid-29440923-etelcalcetide","version":1,"domain":"Literature metadata","dateInSource":"2024-03-13","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"Managing hyperparathyroidism in hemodialysis: role of etelcalcetide.","sourceIds":["pubmed-observation-pmid-29440923-2024-03-13-7f42ac2f90a7"]},{"id":"summary","text":"PubMed lists PMID 29440923 in International journal of nephrology and renovascular disease as Journal Article, Review, with publication-date metadata of 2018-02-05 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-29440923-2024-03-13-7f42ac2f90a7"]},{"id":"paragraph-1","text":"PubMed lists PMID 29440923 in International journal of nephrology and renovascular disease as Journal Article, Review, with publication-date metadata of 2018-02-05 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-29440923-2024-03-13-7f42ac2f90a7"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-29440923-2024-03-13-7f42ac2f90a7"]}],"sources":[{"id":"pubmed-observation-pmid-29440923-2024-03-13-7f42ac2f90a7","name":"PubMed","sourceClass":"A","title":"Managing hyperparathyroidism in hemodialysis: role of etelcalcetide. · retained source version 1:2024-03-13:current:7f42ac2f90a750bfb72d3199588c250899e4a218fd2a1d9651f4cdf6db213a52","url":"https://pubmed.ncbi.nlm.nih.gov/29440923/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"70c5f1e1e2cdb4817e6d522c285b3161186e83d87e3447f6ca74f30bdb7c2ad6","tierARecordSha256":"9bf29df02ff157838266c109c4123a7ff2438c39ba5f6e7f17e11f3e7059faa9"},"integrity":{"algorithm":"sha256","contentSha256":"dc8c27cf8107a5df07882546d2fceb120d801680f3b1920189ed228655668bc8"}},"pubmed-pmid-29691773-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-29691773-etelcalcetide:v1","objectPathId":"pubmed-pmid-29691773-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-29691773-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-29691773-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-29691773-etelcalcetide-v1"},"story":{"slug":"pubmed-pmid-29691773-etelcalcetide","version":1,"domain":"Literature metadata","dateInSource":"2026-10-12","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"Etelcalcetide for Treating Secondary Hyperparathyroidism: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal.","sourceIds":["pubmed-observation-pmid-29691773-2026-10-12-8d8bd4409602"]},{"id":"summary","text":"PubMed lists PMID 29691773 in PharmacoEconomics as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2018-11 (month precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-29691773-2026-10-12-8d8bd4409602"]},{"id":"paragraph-1","text":"PubMed lists PMID 29691773 in PharmacoEconomics as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2018-11 (month precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-29691773-2026-10-12-8d8bd4409602"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-29691773-2026-10-12-8d8bd4409602"]}],"sources":[{"id":"pubmed-observation-pmid-29691773-2026-10-12-8d8bd4409602","name":"PubMed","sourceClass":"A","title":"Etelcalcetide for Treating Secondary Hyperparathyroidism: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal. · retained source version 1:2026-10-12:current:8d8bd4409602d7bd0f843997097f60669c0d177679304f21ce38e7587e46839b","url":"https://pubmed.ncbi.nlm.nih.gov/29691773/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"27b5b7ba4e8705594129f5e064552038043036958c8668b56fd5fa1cc4cf0e54","tierARecordSha256":"50a74945ef1e7b22948a78265ccef78fb877e115360e14a96d17d2a91b687e84"},"integrity":{"algorithm":"sha256","contentSha256":"a0b6f5062468c793c54c1584d1eabdbd1783b44e617daae36739aab73197432c"}},"pubmed-pmid-29719376-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-29719376-etelcalcetide:v1","objectPathId":"pubmed-pmid-29719376-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-29719376-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-29719376-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-29719376-etelcalcetide-v1"},"story":{"slug":"pubmed-pmid-29719376-etelcalcetide","version":1,"domain":"Literature metadata","dateInSource":"2024-11-07","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"Theoretical overview of clinical and pharmacological aspects of the use of etelcalcetide in diabetic patients undergoing hemodialysis.","sourceIds":["pubmed-observation-pmid-29719376-2024-11-07-c8be215fce49"]},{"id":"summary","text":"PubMed lists PMID 29719376 in Drug design, development and therapy as Journal Article, Review, with publication-date metadata of 2018-04-19 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-29719376-2024-11-07-c8be215fce49"]},{"id":"paragraph-1","text":"PubMed lists PMID 29719376 in Drug design, development and therapy as Journal Article, Review, with publication-date metadata of 2018-04-19 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-29719376-2024-11-07-c8be215fce49"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-29719376-2024-11-07-c8be215fce49"]}],"sources":[{"id":"pubmed-observation-pmid-29719376-2024-11-07-c8be215fce49","name":"PubMed","sourceClass":"A","title":"Theoretical overview of clinical and pharmacological aspects of the use of etelcalcetide in diabetic patients undergoing hemodialysis. · retained source version 1:2024-11-07:current:c8be215fce49bd0c60a8933a626a92fe26ffba126d4b8a791dab684614845285","url":"https://pubmed.ncbi.nlm.nih.gov/29719376/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"b18bb02f29512dc65cdb98699b9b17c06ad3343b7aff16eaa3b1df7d643c542b","tierARecordSha256":"067d612f2d813dffc4ea07e23199f0a25572448ef444ca5a7588d815c48ece57"},"integrity":{"algorithm":"sha256","contentSha256":"b9852f0e157a9c15e73b8f6adbfc1421bdbc945fc9835768d6f56f5b4dcc3108"}},"pubmed-pmid-29786181-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-29786181-etelcalcetide:v1","objectPathId":"pubmed-pmid-29786181-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-29786181-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-29786181-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-29786181-etelcalcetide-v1"},"story":{"slug":"pubmed-pmid-29786181-etelcalcetide","version":1,"domain":"Literature metadata","dateInSource":"2019-12-10","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"[New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of Nephrologists form Lombardy].","sourceIds":["pubmed-observation-pmid-29786181-2019-12-10-d0678ed82ae3"]},{"id":"summary","text":"PubMed lists PMID 29786181 in Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia as Practice Guideline, Journal Article, with publication-date metadata of 2018-05 (month precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-29786181-2019-12-10-d0678ed82ae3"]},{"id":"paragraph-1","text":"PubMed lists PMID 29786181 in Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia as Practice Guideline, Journal Article, with publication-date metadata of 2018-05 (month precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-29786181-2019-12-10-d0678ed82ae3"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-29786181-2019-12-10-d0678ed82ae3"]}],"sources":[{"id":"pubmed-observation-pmid-29786181-2019-12-10-d0678ed82ae3","name":"PubMed","sourceClass":"A","title":"[New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of Nephrologists form Lombardy]. · retained source version 1:2019-12-10:current:d0678ed82ae39f8f70242810ef945350431ed7d99cd4a175e48afde3f1376dc1","url":"https://pubmed.ncbi.nlm.nih.gov/29786181/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"fa6d779009cd81c3ab7f587592cc954579ef3c9b3f9ca12e8c15cbec486b982b","tierARecordSha256":"792cc3b45b5835dcadb541b4554b70625e1badbe29f147fa009da094cb9ece3a"},"integrity":{"algorithm":"sha256","contentSha256":"763b9b777211098dde9a4e53c6644939f4c9b012eec7bc048dbc762f9857b469"}},"pubmed-pmid-29927050-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-29927050-etelcalcetide:v1","objectPathId":"pubmed-pmid-29927050-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-29927050-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-29927050-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-29927050-etelcalcetide-v1"},"story":{"slug":"pubmed-pmid-29927050-etelcalcetide","version":1,"domain":"Literature metadata","dateInSource":"2019-12-10","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"Dramatic Regression of Parathyroid Gland Swelling After Conversion of Calcimimetic Medication From Cinacalcet to Etelcalcetide.","sourceIds":["pubmed-observation-pmid-29927050-2019-12-10-8c305765838e"]},{"id":"summary","text":"PubMed lists PMID 29927050 in Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy as Case Reports, Letter, with publication-date metadata of 2018-06-21 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-29927050-2019-12-10-8c305765838e"]},{"id":"paragraph-1","text":"PubMed lists PMID 29927050 in Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy as Case Reports, Letter, with publication-date metadata of 2018-06-21 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-29927050-2019-12-10-8c305765838e"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-29927050-2019-12-10-8c305765838e"]}],"sources":[{"id":"pubmed-observation-pmid-29927050-2019-12-10-8c305765838e","name":"PubMed","sourceClass":"A","title":"Dramatic Regression of Parathyroid Gland Swelling After Conversion of Calcimimetic Medication From Cinacalcet to Etelcalcetide. · retained source version 1:2019-12-10:current:8c305765838e4f7ef32baf09795c6fac1b342e1f11044d717b08c308288a8e7e","url":"https://pubmed.ncbi.nlm.nih.gov/29927050/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"1d137dd2a1a40224927d75869f87c41a77d5745e553b7641330dc3c343e98f6e","tierARecordSha256":"2a3166dc58b847dd31b269d2c1981e841d70c016d3d8e7f5b3935e473c7f624f"},"integrity":{"algorithm":"sha256","contentSha256":"56a680b87d94d5b06ee08df825a933d2a3892eaa40d806ffe56d10367c876dd3"}},"pubmed-pmid-30009474-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-30009474-etelcalcetide:v1","objectPathId":"pubmed-pmid-30009474-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-30009474-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-30009474-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-30009474-etelcalcetide-v1"},"story":{"slug":"pubmed-pmid-30009474-etelcalcetide","version":1,"domain":"Literature metadata","dateInSource":"2019-12-10","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"Treatment of secondary hyperparathyroidism: How do cinacalcet and etelcalcetide differ?","sourceIds":["pubmed-observation-pmid-30009474-2019-12-10-3eea5e65525d"]},{"id":"summary","text":"PubMed lists PMID 30009474 in Seminars in dialysis as Editorial, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2018-07-15 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-30009474-2019-12-10-3eea5e65525d"]},{"id":"paragraph-1","text":"PubMed lists PMID 30009474 in Seminars in dialysis as Editorial, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2018-07-15 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-30009474-2019-12-10-3eea5e65525d"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-30009474-2019-12-10-3eea5e65525d"]}],"sources":[{"id":"pubmed-observation-pmid-30009474-2019-12-10-3eea5e65525d","name":"PubMed","sourceClass":"A","title":"Treatment of secondary hyperparathyroidism: How do cinacalcet and etelcalcetide differ? · retained source version 1:2019-12-10:current:3eea5e65525d5e6ac562cab1ab4229b6ed9d32b45422093873a7089b0ac8ad51","url":"https://pubmed.ncbi.nlm.nih.gov/30009474/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"e915527d7e1964ff73ea37bc03b5c39cdc0d2d4c702b28437428e91923cd4506","tierARecordSha256":"ca245fefeda0a2391b03c2556e9dbc1ebf1fdbc85e531f150051c15d38ed4ce6"},"integrity":{"algorithm":"sha256","contentSha256":"fc413ff7c839b65de95df24a56808949b6f5091e4bf2797ad6f874f0af641b0e"}},"pubmed-pmid-30013296-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-30013296-etelcalcetide:v1","objectPathId":"pubmed-pmid-30013296-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-30013296-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-30013296-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-30013296-etelcalcetide-v1"},"story":{"slug":"pubmed-pmid-30013296-etelcalcetide","version":1,"domain":"Literature metadata","dateInSource":"2024-11-09","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"Etelcalcetide (Parsabiv) for Secondary Hyperparathyroidism in Adults With Chronic Kidney Disease on Hemodialysis.","sourceIds":["pubmed-observation-pmid-30013296-2024-11-09-5d48c19b757a"]},{"id":"summary","text":"PubMed lists PMID 30013296 in P & T : a peer-reviewed journal for formulary management as Journal Article, with publication-date metadata of 2018-07 (month precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-30013296-2024-11-09-5d48c19b757a"]},{"id":"paragraph-1","text":"PubMed lists PMID 30013296 in P & T : a peer-reviewed journal for formulary management as Journal Article, with publication-date metadata of 2018-07 (month precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-30013296-2024-11-09-5d48c19b757a"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-30013296-2024-11-09-5d48c19b757a"]}],"sources":[{"id":"pubmed-observation-pmid-30013296-2024-11-09-5d48c19b757a","name":"PubMed","sourceClass":"A","title":"Etelcalcetide (Parsabiv) for Secondary Hyperparathyroidism in Adults With Chronic Kidney Disease on Hemodialysis. · retained source version 1:2024-11-09:current:5d48c19b757a1d03d966d4da360933113c00dae94a85d8ff7fc6b9d737935925","url":"https://pubmed.ncbi.nlm.nih.gov/30013296/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"4fc4b52ca39ca2c1ec680ee1b18cf60f4987b3ba87b0cbc8dab58a8e1ae2c345","tierARecordSha256":"664c1bea5aecaf91da25b4146b33eb9eb994880b60234cc506f4653e6a1972a2"},"integrity":{"algorithm":"sha256","contentSha256":"1078236e7df1bb876353ce4e46b1f59ca05cec54e0a15867394051cc83f19c0e"}},"pubmed-pmid-31853791-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-31853791-etelcalcetide:v1","objectPathId":"pubmed-pmid-31853791-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-31853791-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-31853791-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-31853791-etelcalcetide-v1"},"story":{"slug":"pubmed-pmid-31853791-etelcalcetide","version":1,"domain":"Literature metadata","dateInSource":"2021-06-04","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of working group on CKD-MBD of the Italian Society of Nephrology.","sourceIds":["pubmed-observation-pmid-31853791-2021-06-04-3b22b6b34abb"]},{"id":"summary","text":"PubMed lists PMID 31853791 in Journal of nephrology as Journal Article, Practice Guideline, with publication-date metadata of 2019-12-18 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-31853791-2021-06-04-3b22b6b34abb"]},{"id":"paragraph-1","text":"PubMed lists PMID 31853791 in Journal of nephrology as Journal Article, Practice Guideline, with publication-date metadata of 2019-12-18 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-31853791-2021-06-04-3b22b6b34abb"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-31853791-2021-06-04-3b22b6b34abb"]}],"sources":[{"id":"pubmed-observation-pmid-31853791-2021-06-04-3b22b6b34abb","name":"PubMed","sourceClass":"A","title":"New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of working group on CKD-MBD of the Italian Society of Nephrology. · retained source version 1:2021-06-04:current:3b22b6b34abb19e477faf26c847c0a1835480b56862f23a59d1e801ab61f775c","url":"https://pubmed.ncbi.nlm.nih.gov/31853791/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"23cd4c3591b68894512bad1de93ec9b720ccc5e8cf8b7a945b3ec50c75e2894d","tierARecordSha256":"45438c48020b61f4fe5beaabb201c65bfb04e1119375657e9211b10ed311b7e6"},"integrity":{"algorithm":"sha256","contentSha256":"551e2087da2fb0218bf12812271b8196afe2a000e8b385484dfb3e25ca916ea5"}},"pubmed-pmid-33305109-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-33305109-etelcalcetide:v1","objectPathId":"pubmed-pmid-33305109-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-33305109-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-33305109-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-33305109-etelcalcetide-v1"},"story":{"slug":"pubmed-pmid-33305109-etelcalcetide","version":1,"domain":"Literature metadata","dateInSource":"2023-11-10","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"A Prospective, Randomized Clinical Trial of Etelcalcetide in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism (the DUET Trial).","sourceIds":["pubmed-observation-pmid-33305109-2023-11-10-5b253f19f4aa"]},{"id":"summary","text":"PubMed lists PMID 33305109 in Kidney international reports as Journal Article, with publication-date metadata of 2020-09-18 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-33305109-2023-11-10-5b253f19f4aa"]},{"id":"paragraph-1","text":"PubMed lists PMID 33305109 in Kidney international reports as Journal Article, with publication-date metadata of 2020-09-18 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-33305109-2023-11-10-5b253f19f4aa"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-33305109-2023-11-10-5b253f19f4aa"]}],"sources":[{"id":"pubmed-observation-pmid-33305109-2023-11-10-5b253f19f4aa","name":"PubMed","sourceClass":"A","title":"A Prospective, Randomized Clinical Trial of Etelcalcetide in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism (the DUET Trial). · retained source version 1:2023-11-10:current:5b253f19f4aae3028c3b8a283393ce5ff99972110ba45167a84ba04a4369b4fc","url":"https://pubmed.ncbi.nlm.nih.gov/33305109/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"ed7b188e9fd03c6c79ab29cb96eed4f4c9364b8523153b9e3f860e75462e5753","tierARecordSha256":"88b7981ab16569e9c28ed9cb373c7460d27ad0c32e730fabf96b8ba27a8c4250"},"integrity":{"algorithm":"sha256","contentSha256":"e8266266918f64fbe21b8f5df2f90dbb203ffb5fe721f680d6fbc9dc5abb1ff6"}},"pubmed-pmid-33825489-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-33825489-etelcalcetide:v1","objectPathId":"pubmed-pmid-33825489-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-33825489-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-33825489-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-33825489-etelcalcetide-v1"},"story":{"slug":"pubmed-pmid-33825489-etelcalcetide","version":1,"domain":"Literature metadata","dateInSource":"2022-01-06","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"Randomized Trial of Etelcalcetide for Cardiac Hypertrophy in Hemodialysis.","sourceIds":["pubmed-observation-pmid-33825489-2022-01-06-c591d3e8507e"]},{"id":"summary","text":"PubMed lists PMID 33825489 in Circulation research as Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2021-04-07 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-33825489-2022-01-06-c591d3e8507e"]},{"id":"paragraph-1","text":"PubMed lists PMID 33825489 in Circulation research as Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2021-04-07 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-33825489-2022-01-06-c591d3e8507e"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-33825489-2022-01-06-c591d3e8507e"]}],"sources":[{"id":"pubmed-observation-pmid-33825489-2022-01-06-c591d3e8507e","name":"PubMed","sourceClass":"A","title":"Randomized Trial of Etelcalcetide for Cardiac Hypertrophy in Hemodialysis. · retained source version 1:2022-01-06:current:c591d3e8507e9a57061c0ca8690907eb4bc6cecb2d01f3ddf06fdd6a41a0b1eb","url":"https://pubmed.ncbi.nlm.nih.gov/33825489/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"2059903a253b354c66047961cb9501710507570f9ee754a00e2fa2c27556b33e","tierARecordSha256":"748fb0eef09ff41ea5f253ef0ef12f78f47a22941613acbede413ab131ecf649"},"integrity":{"algorithm":"sha256","contentSha256":"9fafd066bf587ec6c82b814325fe8a502211ed4c14070260ee55b83e6e455f9c"}},"pubmed-pmid-34787825-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-34787825-etelcalcetide:v1","objectPathId":"pubmed-pmid-34787825-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-34787825-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-34787825-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-34787825-etelcalcetide-v1"},"story":{"slug":"pubmed-pmid-34787825-etelcalcetide","version":1,"domain":"Literature metadata","dateInSource":"2022-07-16","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"A case of a hemodialysis patient with secondary hyperparathyroidism who was resistant to etelcalcetide treatment but not to cinacalcet hydrochloride.","sourceIds":["pubmed-observation-pmid-34787825-2022-07-16-d824de79b3dc"]},{"id":"summary","text":"PubMed lists PMID 34787825 in CEN case reports as Case Reports, Journal Article, with publication-date metadata of 2021-11-17 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-34787825-2022-07-16-d824de79b3dc"]},{"id":"paragraph-1","text":"PubMed lists PMID 34787825 in CEN case reports as Case Reports, Journal Article, with publication-date metadata of 2021-11-17 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-34787825-2022-07-16-d824de79b3dc"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-34787825-2022-07-16-d824de79b3dc"]}],"sources":[{"id":"pubmed-observation-pmid-34787825-2022-07-16-d824de79b3dc","name":"PubMed","sourceClass":"A","title":"A case of a hemodialysis patient with secondary hyperparathyroidism who was resistant to etelcalcetide treatment but not to cinacalcet hydrochloride. · retained source version 1:2022-07-16:current:d824de79b3dcbdfdd726c598015ed019de7ece6d83663dac47cd75d55cb116ba","url":"https://pubmed.ncbi.nlm.nih.gov/34787825/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"0f2ff8c40ae22c2490362609959116923eadf21cecc97bdbe63532b03f1e005a","tierARecordSha256":"2cec3b3c677689c73fbccc9b3cecb8ffaf054f75538db0f005f7214fb2a239ba"},"integrity":{"algorithm":"sha256","contentSha256":"79fe80fee0ac7ca3d8b3cf3321cc9c72fc862dcf58ebd988b7618d70540b3af4"}},"pubmed-pmid-36611532-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-36611532-etelcalcetide:v1","objectPathId":"pubmed-pmid-36611532-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-36611532-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-36611532-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-36611532-etelcalcetide-v1"},"story":{"slug":"pubmed-pmid-36611532-etelcalcetide","version":1,"domain":"Literature metadata","dateInSource":"2023-03-08","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"Etelcalcetide and Paricalcitol in Chronic Kidney Disease: When the Target Is Inflammation.","sourceIds":["pubmed-observation-pmid-36611532-2023-03-08-2e252319ad88"]},{"id":"summary","text":"PubMed lists PMID 36611532 in Healthcare (Basel, Switzerland) as Journal Article, with publication-date metadata of 2022-12-26 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-36611532-2023-03-08-2e252319ad88"]},{"id":"paragraph-1","text":"PubMed lists PMID 36611532 in Healthcare (Basel, Switzerland) as Journal Article, with publication-date metadata of 2022-12-26 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-36611532-2023-03-08-2e252319ad88"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-36611532-2023-03-08-2e252319ad88"]}],"sources":[{"id":"pubmed-observation-pmid-36611532-2023-03-08-2e252319ad88","name":"PubMed","sourceClass":"A","title":"Etelcalcetide and Paricalcitol in Chronic Kidney Disease: When the Target Is Inflammation. · retained source version 1:2023-03-08:current:2e252319ad88731d01a4bb08d2e99e7825e8305efc9e03076967d1d2606e11f1","url":"https://pubmed.ncbi.nlm.nih.gov/36611532/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"1fdb2cb44277d993ac8c9e2e48d167b9573013c8fecb13664168cfc650205eae","tierARecordSha256":"98a25f5738e30c34170e90f56b1dd6798ddbc93f1450972b3c72f48103cd88ba"},"integrity":{"algorithm":"sha256","contentSha256":"90044286c72a01ebf5036bd688fb727995fb8f42e258056c37566fe87c3d15a9"}},"pubmed-pmid-36790677-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-36790677-etelcalcetide:v1","objectPathId":"pubmed-pmid-36790677-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-36790677-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-36790677-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-36790677-etelcalcetide-v1"},"story":{"slug":"pubmed-pmid-36790677-etelcalcetide","version":1,"domain":"Literature metadata","dateInSource":"2026-10-31","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"Long-term use of etelcalcetide for the treatment of secondary hyperparathyroidism in patients undergoing hemodialysis for end-stage renal failure: a real-life retrospective observational study.","sourceIds":["pubmed-observation-pmid-36790677-2026-10-31-68727c48629e"]},{"id":"summary","text":"PubMed lists PMID 36790677 in International urology and nephrology as Observational Study, Journal Article, with publication-date metadata of 2023-02-15 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-36790677-2026-10-31-68727c48629e"]},{"id":"paragraph-1","text":"PubMed lists PMID 36790677 in International urology and nephrology as Observational Study, Journal Article, with publication-date metadata of 2023-02-15 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-36790677-2026-10-31-68727c48629e"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-36790677-2026-10-31-68727c48629e"]}],"sources":[{"id":"pubmed-observation-pmid-36790677-2026-10-31-68727c48629e","name":"PubMed","sourceClass":"A","title":"Long-term use of etelcalcetide for the treatment of secondary hyperparathyroidism in patients undergoing hemodialysis for end-stage renal failure: a real-life retrospective observational study. · retained source version 1:2026-10-31:current:68727c48629ef71cfc7df42acdeaf5342491122ce3896f4df1f1411e3688a3f0","url":"https://pubmed.ncbi.nlm.nih.gov/36790677/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"ecbfd7afaff46d48545c61c4fc53cac00877ab984f52b77acb0a5cf48c795d9d","tierARecordSha256":"5c2750864422fdcf633e6d9a5c85612847f7cd2150f19b4c4b4ae615f5f4e8d0"},"integrity":{"algorithm":"sha256","contentSha256":"c531a6dfe27ed3839e2843f1225381317bc974bbe7f527367e4b5587fbb42e9c"}},"pubmed-pmid-37383843-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-37383843-etelcalcetide:v1","objectPathId":"pubmed-pmid-37383843-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-37383843-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-37383843-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-37383843-etelcalcetide-v1"},"story":{"slug":"pubmed-pmid-37383843-etelcalcetide","version":1,"domain":"Literature metadata","dateInSource":"2024-03-07","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"Acute and Severe Hypercalcemia Early After Kidney Transplantation in a Patient Previously Treated With Etelcalcetide.","sourceIds":["pubmed-observation-pmid-37383843-2024-03-07-3fcfcac80215"]},{"id":"summary","text":"PubMed lists PMID 37383843 in Transplant international : official journal of the European Society for Organ Transplantation as Journal Article, with publication-date metadata of 2023-06-13 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-37383843-2024-03-07-3fcfcac80215"]},{"id":"paragraph-1","text":"PubMed lists PMID 37383843 in Transplant international : official journal of the European Society for Organ Transplantation as Journal Article, with publication-date metadata of 2023-06-13 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-37383843-2024-03-07-3fcfcac80215"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-37383843-2024-03-07-3fcfcac80215"]}],"sources":[{"id":"pubmed-observation-pmid-37383843-2024-03-07-3fcfcac80215","name":"PubMed","sourceClass":"A","title":"Acute and Severe Hypercalcemia Early After Kidney Transplantation in a Patient Previously Treated With Etelcalcetide. · retained source version 1:2024-03-07:current:3fcfcac80215f54ee16753ad4e3e89b86e8b89b0adf6032dd907f838da25fae3","url":"https://pubmed.ncbi.nlm.nih.gov/37383843/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"d4dc6fd4fce0897ba2453379c95eaf5029d4358b88add1912174310a6468c9d8","tierARecordSha256":"2864ddf332932c511f4011ac597773f374d6846b6c01b60a1f4cf1e1216a3c51"},"integrity":{"algorithm":"sha256","contentSha256":"70e40a64d0e852cabd341fb6cc1211a3afc4115ed4aec41463d5624c0684f54a"}},"pubmed-pmid-38050530-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-38050530-etelcalcetide:v1","objectPathId":"pubmed-pmid-38050530-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-38050530-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-38050530-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-38050530-etelcalcetide-v1"},"story":{"slug":"pubmed-pmid-38050530-etelcalcetide","version":1,"domain":"Literature metadata","dateInSource":"2023-12-06","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"Real-World Experience of Using Etelcalcetide for Secondary Hyperparathyroidism in Community-Based Hemodialysis Centers in Singapore.","sourceIds":["pubmed-observation-pmid-38050530-2023-12-06-040745c29c2d"]},{"id":"summary","text":"PubMed lists PMID 38050530 in Cureus as Journal Article, with publication-date metadata of 2023-11-02 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-38050530-2023-12-06-040745c29c2d"]},{"id":"paragraph-1","text":"PubMed lists PMID 38050530 in Cureus as Journal Article, with publication-date metadata of 2023-11-02 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-38050530-2023-12-06-040745c29c2d"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-38050530-2023-12-06-040745c29c2d"]}],"sources":[{"id":"pubmed-observation-pmid-38050530-2023-12-06-040745c29c2d","name":"PubMed","sourceClass":"A","title":"Real-World Experience of Using Etelcalcetide for Secondary Hyperparathyroidism in Community-Based Hemodialysis Centers in Singapore. · retained source version 1:2023-12-06:current:040745c29c2d776e690ca4886ad7bff3ea7d497fc735b1b5039c9ee1d28a65c6","url":"https://pubmed.ncbi.nlm.nih.gov/38050530/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"5e448c823e116cbc4c68537e7080285c186166f915f085da024829767a544e0e","tierARecordSha256":"d0c482c9332d1484a464264c11265a04ee4da11019e81323bf91e3a447173215"},"integrity":{"algorithm":"sha256","contentSha256":"e41cb01011f42163833e0d57c4d7e6fb637b740630ebcae48db0155c46b4539a"}},"pubmed-pmid-39081745-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-39081745-etelcalcetide:v1","objectPathId":"pubmed-pmid-39081745-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-39081745-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-39081745-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-39081745-etelcalcetide-v1"},"story":{"slug":"pubmed-pmid-39081745-etelcalcetide","version":1,"domain":"Literature metadata","dateInSource":"2026-05-18","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"Etelcalcetide use During Maintenance Hemodialysis and Incidence of Parathyroidectomy After Kidney Transplantation.","sourceIds":["pubmed-observation-pmid-39081745-2026-05-18-66f8c490dee0"]},{"id":"summary","text":"PubMed lists PMID 39081745 in Kidney international reports as Journal Article, with publication-date metadata of 2024-04-04 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-39081745-2026-05-18-66f8c490dee0"]},{"id":"paragraph-1","text":"PubMed lists PMID 39081745 in Kidney international reports as Journal Article, with publication-date metadata of 2024-04-04 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-39081745-2026-05-18-66f8c490dee0"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-39081745-2026-05-18-66f8c490dee0"]}],"sources":[{"id":"pubmed-observation-pmid-39081745-2026-05-18-66f8c490dee0","name":"PubMed","sourceClass":"A","title":"Etelcalcetide use During Maintenance Hemodialysis and Incidence of Parathyroidectomy After Kidney Transplantation. · retained source version 1:2026-05-18:current:66f8c490dee0d01821535f2f73ffa6a044750339e177d7e0f3024457c3e4bb06","url":"https://pubmed.ncbi.nlm.nih.gov/39081745/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"1ffd342d9f0d97eb38a78aab84b4961f8573898db90d70e98eaeee88002564a8","tierARecordSha256":"14c6ef0f6c5b4c7e23dfba4bae0048a1fb414e7ccdc05ec7d94dc916b592ca41"},"integrity":{"algorithm":"sha256","contentSha256":"e8baa2406def14b6c752057df7f82f4d50c886877f21f2833cd6b0d03ddf4b6e"}},"pubmed-pmid-39557587-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-39557587-etelcalcetide:v1","objectPathId":"pubmed-pmid-39557587-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-39557587-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-39557587-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-39557587-etelcalcetide-v1"},"story":{"slug":"pubmed-pmid-39557587-etelcalcetide","version":1,"domain":"Literature metadata","dateInSource":"2026-09-10","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"Real world evaluation of etelcalcetide in the treatment of secondary hyperparathyroidism in hemodialysis patients in Argentina.","sourceIds":["pubmed-observation-pmid-39557587-2026-09-10-0b416d0cd0c8"]},{"id":"summary","text":"PubMed lists PMID 39557587 in Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy as Journal Article, Observational Study, Multicenter Study, with publication-date metadata of 2024-11-18 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-39557587-2026-09-10-0b416d0cd0c8"]},{"id":"paragraph-1","text":"PubMed lists PMID 39557587 in Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy as Journal Article, Observational Study, Multicenter Study, with publication-date metadata of 2024-11-18 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-39557587-2026-09-10-0b416d0cd0c8"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-39557587-2026-09-10-0b416d0cd0c8"]}],"sources":[{"id":"pubmed-observation-pmid-39557587-2026-09-10-0b416d0cd0c8","name":"PubMed","sourceClass":"A","title":"Real world evaluation of etelcalcetide in the treatment of secondary hyperparathyroidism in hemodialysis patients in Argentina. · retained source version 1:2026-09-10:current:0b416d0cd0c85acc14c2bd96cccc75d8e63a3ad297d6b4bde8a46d15959b0cae","url":"https://pubmed.ncbi.nlm.nih.gov/39557587/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"597fac8c1778783b7dbf98f02f57469afb4441851ae0ad9a0116f09737579992","tierARecordSha256":"b63da63cbbb21405546dc29b9048147d4171baaaf4570dd394997d4a4d31c01c"},"integrity":{"algorithm":"sha256","contentSha256":"4afcd2e005cdc99288ad06c7c862c2b8d9c591d5aa8d66628096917a373f0818"}},"pubmed-pmid-41307414-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-41307414-etelcalcetide:v1","objectPathId":"pubmed-pmid-41307414-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-41307414-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-41307414-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-41307414-etelcalcetide-v1"},"story":{"slug":"pubmed-pmid-41307414-etelcalcetide","version":1,"domain":"Literature metadata","dateInSource":"2026-09-26","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"Measurement of ionized calcium with a point-of-care ionometer during etelcalcetide therapy.","sourceIds":["pubmed-observation-pmid-41307414-2026-09-26-2836fa1225a8"]},{"id":"summary","text":"PubMed lists PMID 41307414 in Clinical nephrology as Journal Article, Observational Study, Clinical Trial, Phase IV, with publication-date metadata of 2025 (year precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-41307414-2026-09-26-2836fa1225a8"]},{"id":"paragraph-1","text":"PubMed lists PMID 41307414 in Clinical nephrology as Journal Article, Observational Study, Clinical Trial, Phase IV, with publication-date metadata of 2025 (year precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-41307414-2026-09-26-2836fa1225a8"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-41307414-2026-09-26-2836fa1225a8"]}],"sources":[{"id":"pubmed-observation-pmid-41307414-2026-09-26-2836fa1225a8","name":"PubMed","sourceClass":"A","title":"Measurement of ionized calcium with a point-of-care ionometer during etelcalcetide therapy. · retained source version 1:2026-09-26:current:2836fa1225a8767e1d5d8e5f7cdaa32d68c4fa6de6ae594c67cc5dd1a7fa1b0a","url":"https://pubmed.ncbi.nlm.nih.gov/41307414/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"1aa68ca31339de6d3322bd61837b161f05466407e07835e60d2ccf3316d92cfc","tierARecordSha256":"6b1cb0d10531a9fcd8167090263ed4a6c99dcff9f13523a3b4ca0313f0ea9551"},"integrity":{"algorithm":"sha256","contentSha256":"7e4594d5c9c8edaf4840427d875371214f96657dcf9bb277cfdd33a1e9265d78"}},"pubmed-pmid-42739661-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-42739661-etelcalcetide:v1","objectPathId":"pubmed-pmid-42739661-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-42739661-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-42739661-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-42739661-etelcalcetide-v1"},"story":{"slug":"pubmed-pmid-42739661-etelcalcetide","version":1,"domain":"Literature metadata","dateInSource":"2026-09-16","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"Etelcalcetide Versus Cinacalcet for Secondary Hyperparathyroidism in Hemodialysis Patients: A Multicentre Comparison with 24 Months of Follow-Up.","sourceIds":["pubmed-observation-pmid-42739661-2026-09-16-d7317de980c2"]},{"id":"summary","text":"PubMed lists PMID 42739661 in Journal of clinical medicine as Journal Article, with publication-date metadata of 2026-08-28 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-42739661-2026-09-16-d7317de980c2"]},{"id":"paragraph-1","text":"PubMed lists PMID 42739661 in Journal of clinical medicine as Journal Article, with publication-date metadata of 2026-08-28 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-42739661-2026-09-16-d7317de980c2"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-42739661-2026-09-16-d7317de980c2"]}],"sources":[{"id":"pubmed-observation-pmid-42739661-2026-09-16-d7317de980c2","name":"PubMed","sourceClass":"A","title":"Etelcalcetide Versus Cinacalcet for Secondary Hyperparathyroidism in Hemodialysis Patients: A Multicentre Comparison with 24 Months of Follow-Up. · retained source version 1:2026-09-16:current:d7317de980c2831334b2b12f00799560b1c2b2e4d7eaba1a693ec4bbffd9e703","url":"https://pubmed.ncbi.nlm.nih.gov/42739661/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"1710cdee08a30f6930d1e6508f0bae417049f77fea07bfd303894dc64fe674e8","tierARecordSha256":"2ebd76a6450a132c593ffce96a83df8772cd8417dfd31bd780d0ed6e26e9aa19"},"integrity":{"algorithm":"sha256","contentSha256":"19dc56f5c6615dc52dfa64f98e4c43cd560268eb0bffa319220fe82945759d46"}},"pubmed-pmid-42853437-etelcalcetide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-42853437-etelcalcetide:v1","objectPathId":"pubmed-pmid-42853437-etelcalcetide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-42853437-etelcalcetide/","json":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-42853437-etelcalcetide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-42853437-etelcalcetide-v1"},"story":{"slug":"pubmed-pmid-42853437-etelcalcetide","version":1,"domain":"Literature metadata","dateInSource":"2026-10-12","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["etelcalcetide"],"peptides":[{"slug":"etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"}]},"claims":[{"id":"headline","text":"Regression of uremic tumoral calcinosis following the switch from cinacalcet to etelcalcetide in a hemodialysis patient without severe hyperphosphatemia.","sourceIds":["pubmed-observation-pmid-42853437-2026-10-12-1ce7771f6579"]},{"id":"summary","text":"PubMed lists PMID 42853437 in CEN case reports as Journal Article, Case Reports, with publication-date metadata of 2026-10-09 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-42853437-2026-10-12-1ce7771f6579"]},{"id":"paragraph-1","text":"PubMed lists PMID 42853437 in CEN case reports as Journal Article, Case Reports, with publication-date metadata of 2026-10-09 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-42853437-2026-10-12-1ce7771f6579"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-42853437-2026-10-12-1ce7771f6579"]}],"sources":[{"id":"pubmed-observation-pmid-42853437-2026-10-12-1ce7771f6579","name":"PubMed","sourceClass":"A","title":"Regression of uremic tumoral calcinosis following the switch from cinacalcet to etelcalcetide in a hemodialysis patient without severe hyperphosphatemia. · retained source version 1:2026-10-12:current:1ce7771f657969e60cab065566dadadb988be8f61fba289cb28c2a551ecc4227","url":"https://pubmed.ncbi.nlm.nih.gov/42853437/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"4e4cc790c3645445589c6724dc8fac622aef4c342f3977eeb804ca57d446234e","tierARecordSha256":"743185afaa49a43f4382efae2d01a214b20a8c440fbccf306a86aaa2604d2fc0"},"integrity":{"algorithm":"sha256","contentSha256":"dab83f00551b80fc9963978826668acd31c6986df313195c242fcdb4d3b5a4ed"}}}}
